Concepedia

Stephen B. Willingham

SB

29

Publications

8.8K

Citations

26

H-Index

2003

Active since

Affiliations

Stanford University(Current)

University of North Carolina at Chapel Hill

California Institute for Regenerative Medicine

UNC Lineberger Comprehensive Cancer Center

Institute for Stem Cell Biology and Regenerative Medicine

Stephen B. Willingham is an author at Stanford University specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2003–2022

29

Publications

29

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.6K citations · Full text

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Mark P. Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto et al. · Science Translational Medicine · 2010 · 750 citations

Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3

Hanfen Li, Stephen B. Willingham, Jenny P.‐Y. Ting et al. · The Journal of Immunology · 2008 · 646 citations · Full text

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 629 citations · Full text

Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling

Joseph A. Duncan, Dan T. Bergstralh, Yanhong Wang et al. · Proceedings of the National Academy of Sciences · 2007 · 480 citations · Full text

, , +18

Rows per page

1–5 of 29